Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fed Conditions

NCT00960310 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Hirsutism

Interventions

DRUG: Bicalutamide 50 mg Film-Coated Tablets (Sandoz Inc., USA)
DRUG: Bicalutamide 50 mg Film-Coated Tablets (Casodex) (Astrazeneca Pharmaceutical LP, USA)

Sponsor

Sandoz